Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin converting enzyme (ACE) inhibitors.

M J Antonaccio

    Annual Review of Pharmacology and Toxicology
    |January 1, 1982
    PubMed
    Summary

    Angiotensin converting enzyme (ACE) inhibitors significantly reduce high blood pressure and improve heart failure symptoms. Their mechanism involves inhibiting ACE, with future advances expected in this drug class.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine.

    The American journal of physiology·1998
    Same author

    Urokinase-type plasminogen activator stimulates wound healing in the diabetic mouse.

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]·1997
    Same author

    Effects of chronic angiotensin-converting enzyme inhibition on left ventricular and myocyte structure and function during recovery from chronic rapid pacing.

    Journal of molecular and cellular cardiology·1997
    Same author

    Role of Ca2+ in the vascular contraction caused by a thrombin receptor activating peptide.

    European journal of pharmacology·1994
    Same author

    Reduced contractile function after balloon denudation of rat carotid arteries.

    European journal of pharmacology·1994
    Same author

    Considerations for developing an antiarrhythmic agent: a perspective from the pharmaceutical industry.

    The Canadian journal of cardiology·1994

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Angiotensin converting enzyme (ACE) inhibitors are a novel class of drugs.
    • These agents possess a unique inhibitory property.

    Purpose of the Study:

    • To describe the therapeutic applications of ACE inhibitors.
    • To elucidate the mechanism of action of ACE inhibitors.

    Main Methods:

    • The study is a review of existing literature on ACE inhibitors.
    • Focus is on the pharmacological effects and clinical outcomes.

    Main Results:

    • ACE inhibitors effectively reduce elevated blood pressure across various etiologies.
    • Symptoms of digitalis- and diuretic-resistant congestive heart failure are ameliorated.

    Conclusions:

    • The primary mechanism of action is the inhibition of ACE.
    • Further advancements in ACE inhibitors and other renin-angiotensin system inhibitors are anticipated.

    Related Experiment Videos